Skip to main content
SpringerLink
Log in

Searching for diagnostic properties of novel fluorine-18-labeled d-allose

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Two fluorine-18-labeled analogues, 3-deoxy-3-[18F]fluoro-d-allose (3-[18F]FDA) and 6-deoxy-6-[18F]fluoro-d-allose (6-[18F]FDA), were synthesized and their potentials of diagnostic property were characterized.

Methods

In vitro rat red blood cell (RBC) transport and phosphorylation by yeast hexokinase were evaluated in comparison with 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG). The rate of protein binding in pooled human serum was measured by an ultrafiltration method. In vivo metabolite analysis in mice was also performed. Biodistribution, urine excretion, and in vivo renal kinetics in mice were compared with 2-deoxy-2-[18F]fluorosorbitol ([18F]FDS).

Results

Rat RBC uptake of 3- and 6-[18F]FDA (7.8 ± 2.5%ID and 10.2 ± 4.8%ID, respectively) was significantly lower than that of [18F]FDG (44.7 ± 8.7%ID). RBC uptake of 3-[18F]FDA was inhibited by d-glucose (30%) and cytochalasin B (40%), indicating the involvement of GLUT1-dependent transport. In contrast, 6-[18F]FDA transport was not inhibited by d-glucose and cytochalasin B. 3- and 6-[18F]FDA were not phosphorylated by yeast hexokinase under the conditions that result in 60% conversion of [18F]FDG into [18F]FDG-6-phosphate within 30 min. Serum protein binding of 3- and 6-[18F]FDA was negligible. Metabolic transformation of both tracers was not detected in plasma and urine at 30 min after injection. The highest tissue uptake of both tracers was observed in kidneys. Heart and brain uptake of both tracers was below blood levels throughout the biodistribution studies (until 120 min after injection). No significant uptake in the bone was observed, indicating the absence of de-fluorination in mice. In vivo PET imaging visualized rapid excretion of the administered 3- and 6-[18F]FDA from the kidneys, with minimal tracer accumulation in other organs. The urine excretion rate of 3-[18F]FDA was much lower than that of 6-[18F]FDA and [18F]FDS.

Conclusions

3- and 6-[18F]FDA might be unsatisfactory for tumor imaging. In contrast, these tracers demonstrated high levels of kidney uptake and excretion, low serum protein binding, and high metabolic stability as preferable properties for renal imaging. Notably, the urine excretion rate and kidney uptake kinetics of 6-[18F]FDA were comparable with those of the potential renal imaging agent [18F]FDS. Further validation studies in animal models are required to confirm the feasibility of 6-[18F]FDA as a functional renal imaging agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Gao D, Kawai N, Tamiya T. The anti-inflammatory effects of D-allose contribute to attenuation of cerebral ischemia-reperfusion injury. Med Hypothesis. 2011;76:911–3.

    Article  CAS  Google Scholar 

  2. Gao D, Kawai N, Nakamura T, Lu F, Fei Z, Tamiya T. Anti-inflammatory effect of d-allose in cerebral ischemia/reperfusion injury in rats. Neurol Med Chir (Tokyo). 2013;53:365–74.

    Article  Google Scholar 

  3. Shinohara N, Nakamura T, Abe Y, Hifumi T, Kawakita K, Shinomiya A, Tamiya T, Tokuda M, Keep RF, Yamamoto T, Kuroda Y. D-Allose attenuates overexpression of inflammatory cytokines after cerebral ischemia/reperfusion injury in Gerbil. J Stroke Cerebrovasc Dis. 2016;25:2184–8.

    Article  PubMed  Google Scholar 

  4. Ishihara Y, Katayama K, Sakabe M, Kitamura M, Aizawa M, Takara M, Itoh K. Antioxidant properties of rare sugar d-allose: effects on mitochondrial reactive oxygen species production in Neuro2A cells. J Biosci Bioeng. 2011;112:638–42.

    Article  CAS  PubMed  Google Scholar 

  5. Kashiwagi H, Asano E, Noguchi C, Sui L, Hossain A, Akamoto S, Okano K, Tokuda M, Suzuki Y. Beneficial effect of D-allose isolated islet culture prior to islet transplantation. J Hepatobiliary Pancreat Sci. 2016;23:37–42.

    Article  PubMed  Google Scholar 

  6. Yamada K, Noguchi C, Kamitori K, Dong Y, Hirata Y, Hossain MA, Tsukamoto I, Tokuda M, Yamaguchi F. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells. Nutr Res. 2012;32:116–23.

    Article  CAS  PubMed  Google Scholar 

  7. Kimura S, Zhang GX, Nishiyama A, Nagai Y, Nakagawa T, Miyanaka H, Fujisawa Y, Miyatake A, Nagai T, Tokuda M, Abe Y. D-Allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats. J Hypertens. 2005;23:1887–944.

    Article  CAS  PubMed  Google Scholar 

  8. Hirooka K, Miyamoto O, Jinming P, Du Y, Itano T, Baba T, Tokuda M, Shiraga F. Neuroprotective effects of d-allose against retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2006;47:1653–7.

    Article  PubMed  Google Scholar 

  9. Liu Y, Nakamura T, Toyoshima T, Shinomiya A, Tamiya T, Tokuda M, Keep RF, Itano T. The effects of d-allose on transient ischemic neuronal death and analysis of its mechanism. Brain Res Bull. 2014;109:127–31.

    Article  CAS  PubMed  Google Scholar 

  10. Sui L, Dong Y, Watanabe Y, Yamaguchi F, Hatano N, Izumori K, Tokuda M. Growth inhibitory effect of d-allose on human ovarian carcinoma cells in vitro. Anticancer Res. 2005;25:2639–44.

    CAS  PubMed  Google Scholar 

  11. Sui L, Dong Y, Wtanabe Y, Yamaguchi F, Hatano N, Tsukamoto I, Izumori K, Tokuda M. The inhibitory effect and possible mechanisms of d-allose on cancer cell proliferation. Int J Oncol. 2005;27:907–12.

    CAS  PubMed  Google Scholar 

  12. Yamaguchi F, Takata M, Kamitori K, Nonaka M, Dong Y, Sui L, Tokuda M. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27Kip1. Int J Oncol. 2008;32:377–85.

    CAS  PubMed  Google Scholar 

  13. Noguchi C, Kamitori K, Hossain A, Hoshikawa H, Katagi A, Dong Y, Sui L, Tokuda M, Yamaguchi F. d-Allose inhibits cancer cell growth by reducing GLUT1 expression. Tohoku J Exp Med. 2016;238:131–41.

    Article  CAS  PubMed  Google Scholar 

  14. Tewson TJ, Welch MJ, Raichle ME. [18F]-Labeled 3-deoxy-3-fluoro-d-glucose: synthesis and preliminary biodistribution data. J Nucl Med. 1978;19:1339–455.

    CAS  PubMed  Google Scholar 

  15. Neal TR, Schumann WC, Berridge MS, Landau BR. Synthesis of [18F]-6-deoxy-6-fluoro-d-glucose ([18F]6FDG), a potential tracer for glucose transport. J Labelled Comp Radiopharm. 2005;48:845–54.

    Article  CAS  Google Scholar 

  16. Ashique R, Chirakal RV, Hughes DW, Schrobligen GJ. Two-step regio- and stereoselective syntheses of [19F]- and [18F]-2-deoxy-2-(R)-fluoro-β-d-allose. Carbohydr Res. 2006;341:457–66.

    Article  CAS  PubMed  Google Scholar 

  17. Ashique R, Chirakal R, Schrobilgen GJ, Hughes DW, Farncombe T, Gulenchyn K, Labiris R, Truman T, Saab C. Reactivity and selectivity of F2 toward 3,4,6-tri-O-acetyl-d-glucal in anhydrous HF: synthesis of [18F]2-fluoro-2-deoxy-β-d-allose and its use for the detection of a breast tumor. In: Gakh AA, Kirk KL, editors. ACS Symposium Series (Fluorinated Heterocycles) Vol. 1003, Chapter 10, 2019. pp. 211–235.

  18. Iga Y, Matsuo T. D-allose metabolism in rats. J Jpn Soc Nutr Food Sci 2010;63:17–9 (Japanese)

  19. Wakabayashi H, Werner RA, Hayakawa N, Javadi MS, Xinyu C, Hermann K, Rowe SP, Lapa C, Higuchi T. Initial preclinical evaluation of 18F-fluorodeoxysorbitol PET as a novel functional renal imaging agent. J Nucl Med. 2016;57:1625–8.

    Article  CAS  PubMed  Google Scholar 

  20. Werner RA, Wakabayashi H, Chen X, Hirano M, Shinaji T, Lapa C, Rowe SP, Javadi MS, Higuchi T. Functional renal imaging with 18F-FDS PET in rat models of renal disorders. J Nucl Med. 2018;59:828–32.

    Article  CAS  PubMed  Google Scholar 

  21. Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T. Novel functional renal PET imaging with 18F-FDS in human subjects. Clin Nucl Med. 2019;44:410–1.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Li ZB, Wu Z, Cao Q, Dick DW, Tseng JR, Gambhir SS, Chen X. The synthesis of 18F-FDS and its potential application in molecular imaging. Mol Imaging Biol. 2008;10:92–8.

    Article  PubMed  Google Scholar 

  23. Minosako Y, Nemoto M, Ino S, Shirakami Y, Kurami M. Uptake of FDG (2-fluro-2-deoxy-d-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cell. Kaku Igaku 2003;40:23–30 (Japanese)

  24. Van Rijn CJS, Herscheid JDM, Visser GWM, Hoekstra A. On the stereoselectivity of the reaction of [18F]acetylhypofluorite with glucals. Int J Appl Radiat Isot. 1985;36:111–5.

    Article  Google Scholar 

  25. Amini N, Nakao R, Schou M, Halldin C. Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis. J Pharm Biomed Anal. 2014;98:140–3.

    Article  CAS  PubMed  Google Scholar 

  26. Ishii K, Kikuchi Y, Matsuyama S, Kanai Y, Kotani K, Ito T, Yamazaki H, Funaki Y, Iwata R, Itoh M, Yanai K, Hatazawa J, Itoh N, Tanizaki D, Amano D, Yamada M, Yamaguchi T. First achievement of less than 1 mm FWHM resolution in practical semiconductor animal PET scanner. Nucl Instrum Meth A. 2007;576:435–40.

    Article  CAS  Google Scholar 

  27. Loten EG, Regen DM, Park CR. Transport of D-allose by isolated fat-cells: an effect of adenosine trisphosphate on insulin stimulated transport. J Cell Physiol. 1976;89:651–60.

    Article  CAS  PubMed  Google Scholar 

  28. Ullrey DB, Kalckar HM. Search for cellular phosphorylation products of D-allose. Proc Natl Acad Sci USA. 1991;88:1504–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T. The next era of renal radionuclide imaging: novel PET radiotracers. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04359-8.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hofman MS, Hicks RJ. Gallium-68 EDTA PET/CT for renal imaging. Semin Nucl Med. 2016;46:448–61.

    Article  PubMed  Google Scholar 

  31. Qin Z, Hoh CK, Olson ES, Jahromi AH, Hall DJ, Barback CV, You Y-H, Yanagita M, Sharma K, Vera DR. Molecular imaging of the glomerulus via mesangial cell uptake of radiolabeled tilmanocept. J Nucl Med. 2019. https://doi.org/10.2967/jnumed.118.223727.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lipowska M, Jarkas N, Voll RJ, Nye JA, Klenc J, Goodman MM, Taylor AT. Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: radiosynthesis and preclinical evaluation. Nucl Med Biol. 2018;58:42–50.

    Article  CAS  PubMed  Google Scholar 

  33. Awasthi V, Pathuri G, Agashe HB, Gali H. Synthesis and in vivo evaluation of p-18F-fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET. J Nucl Med. 2011;522:147–53.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Mr. Kosuke Nishino and Mr. Masanari Sakai for their technical support with the cyclotron operation and radiosynthesis.

Funding

This work was supported in part by a Grant-in-Aid for Scientific Research (C) No. 18K07658 from the Japan Society for the Promotion of Science and a grant from the Japan Science and Technology Agency SENTAN No. JPMJSN16A1.

Author information

Authors and Affiliations

  1. Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan

    Jun Toyohara & Tetsuro Tago

  2. Department of Radiology and Nuclear Medicine, Akita Cerebrospinal and Cardiovascular Center, 6-10 Senshu-Kubota Machi, Akita, 010-0874, Japan

    Hiroyuki Yamamoto

Authors
  1. Jun Toyohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsuro Tago
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Toyohara.

Ethics declarations

Conflict of interest

Jun Toyohara received a research grant from Sumitomo Heavy Industries (Tokyo, Japan). Hiroyuki Yamamoto and Tetsuro Tago declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 1311 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toyohara, J., Yamamoto, H. & Tago, T. Searching for diagnostic properties of novel fluorine-18-labeled d-allose. Ann Nucl Med 33, 855–865 (2019). https://doi.org/10.1007/s12149-019-01398-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-019-01398-x

Keywords

Search

Navigation